AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Ron Fleishman is the World's Most Underrated Ph... (Sep '15)||4 hr||Lilac||257|
|Santa Clara Mugshots and Criminal Arrest Records (Sep '16)||20 hr||Chol||4|
|El Camino Hospital board restructures by adding...||Tue||Frank Leoheo||8|
|Palo Alto student fights Islamophobia, one dinn...||May 22||Roscoe||7|
|Trump Does Eunuch Tango||May 22||notable quotes||1|
|Trump in Burkha Dancing Pix||May 22||Sensitive Materia...||1|
|'Undocumented' but inspiring (Nov '12)||Mar '17||Andy||44|
Find what you want!
Search Los Altos Forum Now
Copyright © 2017 Topix LLC